TTN and cardiomyopathy: While altering titin phosphorylation and splicing are established therapeutic routes of great interest, modulating levels and/or localization of titin binding partners of the FHL and Ankrd protein family may emerge as a novel avenue for the treatment of cardiomyopathies.